Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
64
NCT04411940
Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions
Phase: Phase 1
Role: Collaborator
Start: Nov 15, 2019
Completion: Dec 18, 2019
NCT04411953
Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions
Completion: Dec 19, 2019